title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd,20230405T110013,https://www.benzinga.com/pressreleases/23/04/g31675058/regenerative-medicine-market-is-projected-to-grow-at-a-cagr-of-18-40-by-2033-visiongain-reports-lt,HLCO,0.028798,Neutral,0.067581
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd,20230313T110000,https://www.benzinga.com/pressreleases/23/03/g31315741/regenerative-medicine-market-is-projected-to-grow-at-a-cagr-of-18-40-by-2033-visiongain-reports-lt,HLCO,0.028798,Neutral,0.067581
Amniotic Membrane Market Size Report  ( $2.80 Billion by 2028 )  Lead by Cryopreserved Amniotic Membrane Segment - Exclusive Report by The Insight Partners,20230221T130822,https://www.benzinga.com/pressreleases/23/02/g30984738/amniotic-membrane-market-size-report-2-80-billion-by-2028-lead-by-cryopreserved-amniotic-membrane-,HLCO,0.030958,Neutral,0.071316
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director,20230130T130000,https://www.benzinga.com/pressreleases/23/01/g30620476/mimedx-appoints-joseph-h-capper-as-chief-executive-officer-and-director,HLCO,0.026213,Somewhat-Bullish,0.330026
MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED - MiMedx Group  ( NASDAQ:MDXG ) ,20230104T210100,https://www.benzinga.com/pressreleases/23/01/g30282316/mimedx-announces-commercial-launch-of-epifix-in-japan-with-exclusive-distribution-agreement-with-g,HLCO,0.033751,Neutral,-0.012823
"BioStem Aims To Stay Ahead Of Competition Through Its Unique Processes And Versatile Offerings In Wound Healing - MiMedx Group  ( NASDAQ:MDXG ) , Organogenesis Hldgs  ( NASDAQ:ORGO ) ",20221208T131227,https://www.benzinga.com/general/biotech/22/12/30005552/biostem-aims-to-stay-ahead-of-competition-through-its-unique-processes-and-versatile-offerings-in,HLCO,0.047465,Somewhat-Bearish,-0.234741
MIMEDX Announces Launch of AMNIOEFFECT™,20220919T110000,https://www.globenewswire.com/news-release/2022/09/19/2518149/0/en/MIMEDX-Announces-Launch-of-AMNIOEFFECT.html,HLCO,0.064276,Neutral,0.002018
MIMEDX EPIFIX® Receives Reimbursement Approval in Japan,20220912T203000,https://www.globenewswire.com/news-release/2022/09/12/2514502/0/en/MIMEDX-EPIFIX-Receives-Reimbursement-Approval-in-Japan.html,HLCO,0.051221,Neutral,0.06597
Doctor's Orders - biotech stocks to watch  ( NASDAQ: LVTX )   ( NASDAQ: NKGN )   ( Nasdaq: KNSA )   ( Nasdaq: GOSS ) ,20240320T133646,https://www.investorideas.com/news/2024/main/03201Stocks.asp,HLCO,0.044801,Somewhat-Bullish,0.177229
